Melissa M. Coughlin

2.3k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

Melissa M. Coughlin is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Melissa M. Coughlin has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Health. Recurrent topics in Melissa M. Coughlin's work include SARS-CoV-2 and COVID-19 Research (18 papers), Virology and Viral Diseases (7 papers) and Vaccine Coverage and Hesitancy (7 papers). Melissa M. Coughlin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (18 papers), Virology and Viral Diseases (7 papers) and Vaccine Coverage and Hesitancy (7 papers). Melissa M. Coughlin collaborates with scholars based in United States, Uganda and Nigeria. Melissa M. Coughlin's co-authors include Bellur S. Prabhakar, Susan C. Baker, Arun K. Ghosh, Katrina Sleeman, Andrew D. Mesecar, Michael E. Johnson, Jun Takayama, Rima Chaudhuri, Kiira Ratia and Hatem A. Elshabrawy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and PLoS ONE.

In The Last Decade

Melissa M. Coughlin

23 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022

2023 72 citations Jefferson M. Jones, Mars Stone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa M. Coughlin United States	12	768	276	242	143	141	27	1.2k
Dewald Schoeman South Africa	6	1.0k 1.3×	345 1.3×	153 0.6×	112 0.8×	78 0.6×	7	1.4k
Lijun Quan China	6	1.3k 1.7×	404 1.5×	196 0.8×	126 0.9×	71 0.5×	10	1.7k
Zhaozhong Zhu China	10	1.3k 1.7×	524 1.9×	162 0.7×	145 1.0×	93 0.7×	18	2.0k
Erica L. Andres United States	5	1.6k 2.1×	386 1.4×	141 0.6×	124 0.9×	233 1.7×	6	1.9k
Lorenzo Subissi Switzerland	16	1.2k 1.6×	415 1.5×	197 0.8×	93 0.7×	190 1.3×	42	1.7k
Prathanporn Kaewpreedee Hong Kong	3	1.2k 1.5×	182 0.7×	145 0.6×	95 0.7×	120 0.9×	5	1.5k
Taylor Heald‐Sargent United States	10	826 1.1×	152 0.6×	77 0.3×	106 0.7×	175 1.2×	20	1.1k
Anurodh Shankar Agrawal United States	19	1.1k 1.4×	308 1.1×	88 0.4×	251 1.8×	397 2.8×	23	1.6k

Countries citing papers authored by Melissa M. Coughlin

Since Specialization

Citations

This map shows the geographic impact of Melissa M. Coughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa M. Coughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa M. Coughlin more than expected).

Fields of papers citing papers by Melissa M. Coughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa M. Coughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa M. Coughlin. The network helps show where Melissa M. Coughlin may publish in the future.

Co-authorship network of co-authors of Melissa M. Coughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa M. Coughlin. A scholar is included among the top collaborators of Melissa M. Coughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa M. Coughlin. Melissa M. Coughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grebe, Eduard, Mars Stone, Bryan R. Spencer, et al.. (2025). Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting. Emerging infectious diseases. 31(5). 958–966. 1 indexed citations

Sayi, Takudzwa S., Umid Sharapov, Melissa M. Coughlin, et al.. (2025). Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trial. The Lancet Child & Adolescent Health. 9(5). 306–314. 2 indexed citations

Jones, Jefferson M., Eduard Grebe, Mars Stone, et al.. (2025). Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022. The Journal of Infectious Diseases. 232(6). 1302–1308.

Sandford, Ryan, Kelsey M. Sumner, Sara Y. Tartof, et al.. (2024). Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022. Influenza and Other Respiratory Viruses. 18(7). e13339–e13339.

Okunromade, Oyeladun, Abiodun Egwuenu, Oladipo Ogunbode, et al.. (2024). The impact of sub-national heterogeneities in demography and epidemiology on the introduction of rubella vaccination programs in Nigeria. Vaccine. 42(20). 125982–125982. 4 indexed citations

Grebe, Eduard, Mars Stone, Bryan R. Spencer, et al.. (2024). Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors. Emerging infectious diseases. 30(8). 1621–1630. 8 indexed citations

Sumner, Kelsey M., Ruchi Yadav, Ryan Sandford, et al.. (2024). Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022. The Journal of Infectious Diseases. 230(1). 45–54. 4 indexed citations

Coughlin, Melissa M., et al.. (2024). Multiplex Bead Assay for the Serological Surveillance of Measles and Rubella. Methods in molecular biology. 2808. 225–246.

Cooley, Gretchen, et al.. (2024). shinyMBA: a novel R shiny application for quality control of the multiplex bead assay for serosurveillance studies. Scientific Reports. 14(1). 7442–7442.

10.

Tohme, Rania A., Heather M. Scobie, Oyeladun Okunromade, et al.. (2023). Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?. Vaccines. 11(3). 663–663. 10 indexed citations

11.

Morice, Ana, María Paz Ade, Gloria Rey-Benito, et al.. (2023). Lessons learned from the implementation of integrated serosurveillance of communicable diseases in the Americas. Revista Panamericana de Salud Pública. 47. 1–1. 5 indexed citations

12.

Bankamp, Bettina, et al.. (2023). Characterizing infection of B cells with wild-type and vaccine strains of measles virus. iScience. 26(10). 107721–107721. 1 indexed citations

13.

Coughlin, Melissa M., Marcus L. Collins, Courtney Jarrahian, et al.. (2015). Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model. Vaccine. 33(36). 4540–4547. 3 indexed citations

14.

Elshabrawy, Hatem A., Melissa M. Coughlin, Susan C. Baker, & Bellur S. Prabhakar. (2012). Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing. PLoS ONE. 7(11). e50366–e50366. 131 indexed citations

15.

Coughlin, Melissa M., John S. Babcook, & Bellur S. Prabhakar. (2009). Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms. Virology. 394(1). 39–46. 24 indexed citations

16.

Ghosh, Arun K., Jun Takayama, Kiira Ratia, et al.. (2009). Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease. Journal of Medicinal Chemistry. 52(16). 5228–5240. 109 indexed citations

17.

Ratia, Kiira, Scott D. Pegan, Jun Takayama, et al.. (2008). A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proceedings of the National Academy of Sciences. 105(42). 16119–16124. 366 indexed citations

18.

Ghosh, Arun K., Gangli Gong, Valerie Grum‐Tokars, et al.. (2008). Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5684–5688. 89 indexed citations

19.

Coughlin, Melissa M., Osvaldo Martinez, Ole Olsen, et al.. (2006). Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse®. Virology. 361(1). 93–102. 51 indexed citations

20.

Pichtel, John, et al.. (2004). Phytoremediation of Soil Contaminated with Used Motor Oil: I. Enhanced Microbial Activities from Laboratory and Growth Chamber Studies. Environmental Engineering Science. 21(2). 157–168. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact